Abstract
PLATIPARP: A phase 2 study of induction docetaxel and carboplatin followed by maintenance rucaparib in treatment of patients with mCRPC with homologous recombination DNA repair deficiency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have